Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac (CVAC) Assets Average (2021 - 2025)

Historic Assets Average for CureVac (CVAC) over the last 5 years, with Q3 2025 value amounting to $1.1 billion.

  • CureVac's Assets Average rose 3727.28% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 3727.28%. This contributed to the annual value of $853.0 million for FY2024, which is 115.86% down from last year.
  • CureVac's Assets Average amounted to $1.1 billion in Q3 2025, which was up 3727.28% from $780.3 million recorded in Q2 2025.
  • CureVac's 5-year Assets Average high stood at $2.1 billion for Q3 2021, and its period low was $674.9 million during Q2 2024.
  • Moreover, its 5-year median value for Assets Average was $948.3 million (2023), whereas its average is $1.0 billion.
  • In the last 5 years, CureVac's Assets Average plummeted by 5385.39% in 2022 and then surged by 3727.28% in 2025.
  • Quarter analysis of 5 years shows CureVac's Assets Average stood at $1.6 billion in 2021, then crashed by 45.35% to $898.0 million in 2022, then fell by 1.71% to $882.7 million in 2023, then rose by 1.74% to $898.0 million in 2024, then grew by 17.53% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $780.3 million for Q2 2025, and $819.3 million during Q1 2025.